PCOS in Teenagers: Why the Criteria Are Different Before 18

Why does PCOS need a different rulebook before 18?

Adolescent PCOS is diagnosed on two features instead of three, and each one has to be held to a stricter, longer timeline than the adult version — a deliberate trade-off, made explicitly to avoid labelling normal puberty as a lifelong condition.

The adult Rotterdam criteria require two of three: irregular cycles, excess androgens, or polycystic ovarian morphology on ultrasound (or a raised AMH). The 2023 international guideline’s adolescent-specific recommendations drop the ultrasound/AMH leg of that tripod entirely and require both of the remaining two — irregular cycles and hyperandrogenism — to be present together, with the cycle irregularity confirmed against age-since-menarche windows rather than a single reading. Puberty itself produces irregular cycles, occasional acne and, on a scan, ovaries that can look polycystic in perfectly healthy teenagers. A test built for adults would flag a large share of normal development as disease.

How long after your first period does “irregular” actually count?

Cycles shorter than 21 or longer than 45 days become diagnostically relevant only from one year after menarche, and the threshold tightens again after three years — the guideline uses time since your first period, not your age, to decide what counts as abnormal.

That first row does most of the work in preventing overdiagnosis. In the year right after menarche, cycles are commonly anovulatory and irregular simply because the hormonal feedback loop that regulates ovulation is still maturing — that pattern, on its own, is not evidence of anything.

What counts as excess androgens in a teenager?

Severe or persistent acne and hirsutism count toward diagnosis, but ordinary teenage breakouts do not — the guideline specifically requires severe acne, or hirsutism scored on a validated scale, or a raised androgen level from a high-quality assay, not a passing skin complaint.

Biochemical hyperandrogenism has the same assay requirement in adolescents as it does in adults: calculated free testosterone or the free androgen index, run on a validated platform. Direct immunoassays for testosterone are not accurate enough at the low concentrations typical of female physiology and are advised against at any age. Mild acne alone, without menstrual irregularity or a validated androgen finding, does not meet the bar — most teenagers have some acne, and using it alone as a criterion would again overdiagnose a normal feature of adolescence.

Why doesn’t an ultrasound diagnose PCOS in a teenager?

A pelvic ultrasound is not recommended for diagnosing PCOS within 8 years of a first period, and AMH is not used for diagnosis in this age group at all — a stricter rule than the adult pathway, where AMH is now an accepted substitute for the scan.

The reason is anatomical, not administrative. Adolescent ovaries are naturally larger and carry more follicles than adult ovaries as a normal feature of reproductive maturation, so the same follicle counts and volume thresholds that flag polycystic morphology in an adult would flag a large share of healthy teenagers. The consortium guideline is explicit that polycystic ovarian morphology on ultrasound, without hyperandrogenism or menstrual irregularity alongside it, should not be used to diagnose adolescent PCOS on its own. If a clinic recommends a scan for diagnosis within that 8-year window, it is reasonable to ask why, given the guideline position.

What if the picture is incomplete — is there a middle category?

An “at risk” label exists specifically for adolescents who have some PCOS features without yet meeting full criteria — the guideline treats this as a real clinical position, with planned re-evaluation, not a way of avoiding the question.

Where only menstrual irregularity or only hyperandrogenism is present, re-evaluation is recommended once three years have passed since menarche for the cycle criterion, or once eight years have passed for the ultrasound-based criterion to become usable at all. Meanwhile, symptoms are treated on their own terms — irregular bleeding, acne or hirsutism do not have to wait for a formal label before they are addressed.

What warrants waiting, and what warrants testing now?

Cycles that are irregular in the first year after a first period warrant waiting, not testing — but severe acne, marked hirsutism, no period at all by age 15, or irregular cycles alongside clear androgen signs at any point warrant testing now, because those patterns sit outside what normal puberty produces.

Concretely:

• Wait and re-observe: irregular cycles alone, in the first year after menarche. This is the expected pattern of a maturing hormonal axis, not a red flag.
• Track, and reassess at the 3-year mark: irregular cycles persisting into years 1–3 post- menarche without any androgen signs. Bring dated cycle history to a routine appointment rather than seeking urgent testing.
• Test now: no period by age 15 or more than 3 years after breast development began; severe or persistent acne; hirsutism scored as clinically significant; or irregular cycles occurring together with any androgen sign, regardless of how long it has been since menarche.
• Test urgently, regardless of age: rapid-onset hair growth or a deepening voice over months rather than years — the same red flags that apply to adults, because they point to a cause more urgent than PCOS.

Whichever category applies, the exclusion bloods still matter at any age: TSH, prolactin and 17-hydroxyprogesterone rule out thyroid disease, high prolactin and non-classical CAH, all of which mimic this picture. When in the cycle those tests should actually be drawn affects how reliable the result is — timing errors are common enough to be worth checking before repeating a test.

Does this mean a teenager should lose weight to fix it?

No single body size defines adolescent PCOS, and weight is one metabolic factor among several, not the target of treatment on its own — the guideline frames lifestyle support as protective against excess weight gain over time, alongside symptom treatment, not as the primary fix for a diagnosis.

Where hyperinsulinaemia or insulin resistance are present in a teenager with PCOS, the guideline notes they are common findings but are not themselves diagnostic criteria — they describe part of the metabolic picture rather than defining the condition. Combined oral contraceptives and metformin are the medications with the most evidence for adolescent symptom management, prescribed and monitored by a clinician rather than self-directed.

Who this does not settle — the honest limits

A “PCOS” label given at 15 is not guaranteed to be the same diagnosis at 25, because some adolescents who meet only the softer, one-criterion version of this picture resolve it as puberty finishes — which is exactly why the guideline built a re-evaluation step in rather than a single irreversible label.

This also is not a framework for testing a symptom-free younger sibling or daughter just because a relative has PCOS; family history changes what to watch for, not what to test for immediately. And it is not a same-day diagnosis pathway: the cycle-length windows exist specifically because a single irregular cycle, or even several in the first year, are expected to happen and are expected to resolve without intervention.

Your next step, this week

For the broader symptom picture beyond the diagnostic criteria themselves, PCOS symptoms in teenagers covers what else commonly shows up at this age.

Write down the date of your first period, the length of your last six cycles if you can reconstruct them, and whether acne or hair growth started gradually or suddenly. That single timeline is what turns “my periods are irregular” into a specific, testable claim a clinician can act on, because almost every threshold above is defined by time since menarche rather than by age alone.

If the picture fits “test now,” the next step is the standard exclusion panel described on what actually gets tested for a PCOS diagnosis, drawn at the correct point in the cycle to avoid a false reading. If it fits “wait and track,” that is not a dismissal — it is the guideline-recommended path, and it comes with a defined date to revisit. The wider diagnosis section covers what a confirmed diagnosis leads to next.

One naming note: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by international consensus. None of the adolescent criteria above changed — only the label did. This article uses PCOS because that is still what most people search.